(6585) Omniwire
Total Payments
$663,387
Transactions
748
Doctors
421
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1,172 | 46 | 27 |
| 2023 | $646,314 | 337 | 181 |
| 2022 | $9,270 | 192 | 141 |
| 2021 | $5,723 | 136 | 110 |
| 2020 | $907.89 | 37 | 30 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $634,787 | 79 | 95.7% |
| Food and Beverage | $28,600 | 669 | 4.3% |
Payments by Type
Research
$634,787
79 transactions
General
$28,600
669 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Distal Evaluation of Functional Performance With Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting (DEFINE GPS) | Philips Electronics North America Corporation | $634,787 | 1 |
Top Doctors Receiving Payments for (6585) Omniwire
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Julia Hecker | — | San Francisco, CA | $624,155 | 76 |
| , MD | Internal Medicine | Sioux Falls, SD | $10,670 | 5 |
| , MD | Cardiovascular Disease | Saint Louis, MO | $2,394 | 25 |
| , MD | Internal Medicine | Saint Louis, MO | $974.85 | 9 |
| , MD | Internal Medicine | Saint Louis, MO | $647.96 | 7 |
| , MD | Interventional Cardiology | New Orleans, LA | $509.77 | 9 |
| , M.D | Cardiovascular Disease | Los Angeles, CA | $483.32 | 13 |
| , MD | Critical Care Medicine | Saint Louis, MO | $349.67 | 3 |
| , M.D | Cardiovascular Disease | Rolla, MO | $333.71 | 3 |
| , M.D | Interventional Cardiology | Springfield, MO | $323.86 | 5 |
| , MD | Cardiovascular Disease | Saint Louis, MO | $319.99 | 5 |
| , M.D | Interventional Cardiology | Beverly Hills, CA | $302.75 | 10 |
| , M.D | Specialist | Slidell, LA | $299.96 | 5 |
| , M.D | Internal Medicine | Springfield, MO | $291.36 | 4 |
| , MD, PHD | Cardiovascular Disease | Brookline, MA | $289.07 | 2 |
| , MD | Cardiovascular Disease | Bradenton, FL | $281.46 | 3 |
| , MD | Cardiovascular Disease | Indianapolis, IN | $277.96 | 3 |
| , M.D | Interventional Cardiology | Saint Louis, MO | $258.43 | 3 |
| , MD | Cardiovascular Disease | Longmont, CO | $255.45 | 3 |
| , M.D | Cardiovascular Disease | Springfield, MO | $248.60 | 4 |
| , MD | Cardiovascular Disease | Syracuse, NY | $234.52 | 11 |
| , MD | Cardiovascular Disease | New York, NY | $225.56 | 2 |
| , M.D | Interventional Cardiology | Birmingham, AL | $223.13 | 4 |
| , MD | Internal Medicine | Jonesboro, AR | $222.99 | 2 |
| , M.D | Cardiovascular Disease | Niagara Falls, NY | $211.77 | 3 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $663,387
- Total Doctors 421
- Transactions 748
About (6585) Omniwire
(6585) Omniwire is a device associated with $663,387 in payments to 421 healthcare providers, recorded across 748 transactions in the CMS Open Payments database. The primary manufacturer is Philips Electronics North America Corporation.
Payment data is available from 2020 to 2024. In 2024, $1,172 was paid across 46 transactions to 27 doctors.
The most common payment nature for (6585) Omniwire is "Unspecified" ($634,787, 95.7% of total).
(6585) Omniwire is associated with 1 research study, including "Distal Evaluation of Functional Performance With Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting (DEFINE GPS)" ($634,787).